Squarepoint’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,435
| Closed | -$75.4K | – | 2918 |
|
|
2024
Q3 | $75.4K | Sell |
27,435
-56,639
| -67% | -$156K | ﹤0.01% | 2390 |
|
|
2024
Q2 | $190K | Buy |
84,074
+36,139
| +75% | +$81.7K | ﹤0.01% | 2156 |
|
|
2024
Q1 | $115K | Buy |
+47,935
| New | +$115K | ﹤0.01% | 2231 |
|
|
2022
Q1 | – | Sell |
-13,182
| Closed | -$27K | – | 2450 |
|
|
2021
Q4 | $27K | Sell |
13,182
-26,009
| -66% | -$53.3K | ﹤0.01% | 2465 |
|
|
2021
Q3 | $152K | Sell |
39,191
-16,937
| -30% | -$65.7K | ﹤0.01% | 1923 |
|
|
2021
Q2 | $180K | Buy |
+56,128
| New | +$180K | ﹤0.01% | 2272 |
|
|
2020
Q1 | – | Sell |
-14,537
| Closed | -$42K | – | 2068 |
|
|
2019
Q4 | $42K | Buy |
14,537
+636
| +5% | +$1.84K | ﹤0.01% | 2308 |
|
|
2019
Q3 | $51K | Buy |
13,901
+3,788
| +37% | +$13.9K | ﹤0.01% | 2134 |
|
|
2019
Q2 | $42K | Buy |
+10,113
| New | +$42K | ﹤0.01% | 2218 |
|
|
2018
Q4 | – | Sell |
-29,525
| Closed | -$177K | – | 2027 |
|
|
2018
Q3 | $177K | Buy |
29,525
+12,947
| +78% | +$77.6K | ﹤0.01% | 1794 |
|
|
2018
Q2 | $105K | Buy |
+16,578
| New | +$105K | ﹤0.01% | 1638 |
|